DE:78Q Stock Latest News
Company AnnouncementsPhilogen Expands Treasury Stock Through Ongoing Share Buyback6d ago
Company AnnouncementsPhilogen Continues Share Buyback, Accumulating Nearly 1% of Capital1w ago
Company AnnouncementsPhilogen Expands Treasury Position Under Ongoing Share Buyback2w ago
Company AnnouncementsMediobanca Steps Up Trading Activity in Listed Shares of Philogen3w ago- Company AnnouncementsPhilogen Updates on Modest Progress in Ongoing Share Buyback Program1M ago
Company AnnouncementsPhilogen expands treasury stake with continued share buybacks1M ago
Company AnnouncementsMediobanca Reports Purchase of Philogen Shares on Italian Market3M ago
Company AnnouncementsPhilogen Updates Share Buyback as Treasury Stake Nears 0.9% of Capital3M ago- Company AnnouncementsPhilogen resubmits strengthened EMA application for melanoma drug Nidlegy3M ago
- Company AnnouncementsPhilogen Publishes Shareholders’ Meeting Minutes and Highlights Targeted Cancer-Drug Focus5M ago
Company AnnouncementsPhilogen Maintains Strong Cash Position as Oncology Pipeline Advances on Schedule5M ago
Company AnnouncementsPhilogen Approves 2025 Results, €0.70 Dividend and New Share Buyback Mandate6M ago
Company AnnouncementsPhilogen Continues Euronext Milan Share Buyback, Nears 0.9% Treasury Stake6M ago
Company AnnouncementsPhilogen Details Voting Rights Structure Ahead of April 29 Shareholders’ Meeting6M ago
Company AnnouncementsPhilogen Adds to Treasury Stock as Biotech Group Advances Targeted Cancer Strategy6M ago
Company AnnouncementsPhilogen Expands Treasury Stock Position as Share Buyback Programme Progresses6M ago
Company AnnouncementsPhilogen Publishes 2025 Financial and Governance Reports Ahead of April 2026 Shareholders’ Meeting6M ago
Company AnnouncementsPhilogen Publishes Documentation Ahead of April 2026 Shareholders’ Meeting7M ago